AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice
- PMID: 16492745
- PMCID: PMC1413872
- DOI: 10.1073/pnas.0507313103
AMPA receptor downscaling at the onset of Alzheimer's disease pathology in double knockin mice
Abstract
It is widely thought that Alzheimer's disease (AD) begins as a malfunction of synapses, eventually leading to cognitive impairment and dementia. Homeostatic synaptic scaling is a mechanism that could be crucial at the onset of AD but has not been examined experimentally. In this process, the synaptic strength of a neuron is modified so that the overall excitability of the cell is maintained. Here, we investigate whether synaptic scaling mediated by l-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) contributes to pathology in double knockin (2 x KI) mice carrying human mutations in the genes for amyloid precursor protein and presenilin-1. By using whole-cell recordings, we show that 2 x KI mice exhibit age-related downscaling of AMPAR-mediated evoked currents and spontaneous, miniature currents. Electron microscopic analysis further corroborates the synaptic AMPAR decrease. Additionally, 2 x KI mice show age-related deficits in bidirectional plasticity (long-term potentiation and long-term depression) and memory flexibility. These results suggest that AMPARs are important synaptic targets for AD and provide evidence that cognitive impairment may involve downscaling of postsynaptic AMPAR function.
Conflict of interest statement
Conflict of interest statement: No conflicts declared.
Figures
Similar articles
-
TRPV1 activation alleviates cognitive and synaptic plasticity impairments through inhibiting AMPAR endocytosis in APP23/PS45 mouse model of Alzheimer's disease.Aging Cell. 2020 Mar;19(3):e13113. doi: 10.1111/acel.13113. Epub 2020 Feb 14. Aging Cell. 2020. PMID: 32061032 Free PMC article.
-
Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3.Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6526-E6534. doi: 10.1073/pnas.1614249113. Epub 2016 Oct 5. Proc Natl Acad Sci U S A. 2016. PMID: 27708157 Free PMC article.
-
Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease.Neuropharmacology. 2017 Jan;112(Pt A):221-227. doi: 10.1016/j.neuropharm.2016.08.022. Epub 2016 Aug 22. Neuropharmacology. 2017. PMID: 27561971 Review.
-
Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.Eur J Neurosci. 2006 Apr;23(8):2035-47. doi: 10.1111/j.1460-9568.2006.04733.x. Eur J Neurosci. 2006. PMID: 16630051
-
Hippocampal synaptic plasticity in Alzheimer's disease: what have we learned so far from transgenic models?Rev Neurosci. 2011;22(4):373-402. doi: 10.1515/RNS.2011.035. Epub 2011 Jul 6. Rev Neurosci. 2011. PMID: 21732714 Review.
Cited by
-
A delay in vesicle endocytosis by a C-terminal fragment of N-cadherin enhances Aβ synaptotoxicity.Cell Death Discov. 2023 Dec 8;9(1):444. doi: 10.1038/s41420-023-01739-w. Cell Death Discov. 2023. PMID: 38062019 Free PMC article.
-
Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer's and Parkinson's Diseases: Insights into Current Medications.Biomolecules. 2023 Nov 3;13(11):1609. doi: 10.3390/biom13111609. Biomolecules. 2023. PMID: 38002291 Free PMC article. Review.
-
Genetic variants of phospholipase C-γ2 alter the phenotype and function of microglia and confer differential risk for Alzheimer's disease.Immunity. 2023 Sep 12;56(9):2121-2136.e6. doi: 10.1016/j.immuni.2023.08.008. Epub 2023 Sep 1. Immunity. 2023. PMID: 37659412
-
Higher Neuronal Facilitation and Potentiation with APOE4 Suppressed by Angiotensin II.Mol Neurobiol. 2024 Jan;61(1):120-131. doi: 10.1007/s12035-023-03556-9. Epub 2023 Aug 17. Mol Neurobiol. 2024. PMID: 37589833 Free PMC article.
-
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future.Signal Transduct Target Ther. 2023 Jun 30;8(1):248. doi: 10.1038/s41392-023-01484-7. Signal Transduct Target Ther. 2023. PMID: 37386015 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
